why choose us

First received: February 27, 2023

Clinical Trial: A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Hepatitis D Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Open-Label, Parallel-Design, Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Bulevirtide in Participants With Normal and Impaired Renal Function

Brief Summary: The goals of this study are to compare the amount of study drug, bulevirtide (BLV), that gets into the bloodstream and how long it takes for the body to eliminate it, measure the effect of BLV on bile acids, and evaluate the safety and tolerability of multiple doses of BLV in participants with normal or impaired renal (kidney) function.

Read more